Evidence map›Paper›PMID 22015712›Full record

ArticleImmunogenetics2012

Non-classical MHC-Ι genes in chronic hepatitis B and hepatocellular carcinoma.

Jian Zhang, Lelin Pan, Luyan Chen, Xiaowen Feng, Lin Zhou, Shusen Zheng

Abstract read
PubMed Publisher
In one paragraph

Article in Immunogenetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Dimorphism of HLA-E and its Disease Association.International journal of molecular sciences · 2019
    Review
  4. Article
  5. Clinical Relevance of HLA Gene Variants in HBV Infection.Journal of immunology research · 2016
    Review
  6. Article
  7. HLA-E: a novel player for histocompatibility.Journal of immunology research · 2014
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Jian ZhangKey Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, The First Affiliated Hospital, School of Medicine Zhejiang University, 310003, Hangzhou, Zhejiang Province, People's Republic of China.
Lelin Pan
Luyan Chen
Xiaowen Feng
Lin Zhou
Shusen Zheng
Zhejiang University · CNMinistry of Public Health · MG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The non-classical human leukocyte antigens (HLA)-E, HLA-G, and HLA-F have been shown to modulate immune responses. We examined whether non-classical HLA polymorphisms are associated with hepatitis B virus (HBV) infection and hepatocellular carcinoma (HCC). Fifteen Single-nucleotide polymorphisms (SNPs) in these non-classical class I alleles were investigated by ligase detection reaction. A fragment of 650 bp located in the 3' untranslated region of HLA-G was investigated. Four SNPs (rs17875380, rs41557518, rs114465251, and rs115492845) were associated with altered susceptibility to HBV or HCC, and HLA-F*01:04, HLA-G*01:05N, and HLA-E*01:01 were associated with hepatitis B or hepatitis B complicated with HCC. Six of 16 designated HLA-E, -G, and -F haplotypes were associated with risk of hepatitis B or HCC. Our study provides healthy reference and detailed analyses of non-classical HLA class Ι polymorphisms that provide insight into immune mechanisms involved in susceptibility to hepatitis B and HCC.

Indexed as

AllelesCarcinoma, HepatocellularCase-Control StudiesGenotypeHepatitis B, ChronicHistocompatibility Antigens Class IHumansLinkage DisequilibriumLiver NeoplasmsPolymorphism, Single NucleotideHistocompatibility Antigens Class I

Identifiers

PMID22015712
OpenAlexW2066503088

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.